FRBN
Closed
Forbion European Acquisition Corp
21.695
0.000 (0.00%)
Last Update: 03 Nov 2023 16:30:00
Yesterday: 21.695
Day's Range: 21.695 - 21.695
Send
sign up or login to leave a comment!
When Written:
10.54
Forbion European Acquisition Corp is a special purpose acquisition company (SPAC) that was formed in 2021 with the purpose of acquiring a European healthcare company. The company is sponsored by Forbion Capital Partners, a leading European life sciences venture capital firm.
The company raised $345 million in its initial public offering (IPO) in February 2021, with the aim of targeting a healthcare company in Europe with a focus on biopharmaceuticals, medical technology, and diagnostics.
Forbion European Acquisition Corp is led by a team of experienced healthcare professionals, including its CEO, Sander Slootweg, who previously served as a managing director at Forbion Capital Partners.
The company has not yet announced any potential acquisition targets, but it is actively seeking opportunities to acquire a European healthcare company that has the potential for significant growth and value creation.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company raised $345 million in its initial public offering (IPO) in February 2021, with the aim of targeting a healthcare company in Europe with a focus on biopharmaceuticals, medical technology, and diagnostics.
Forbion European Acquisition Corp is led by a team of experienced healthcare professionals, including its CEO, Sander Slootweg, who previously served as a managing director at Forbion Capital Partners.
The company has not yet announced any potential acquisition targets, but it is actively seeking opportunities to acquire a European healthcare company that has the potential for significant growth and value creation.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








